Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2.
Baggen J, Persoons L, Vanstreels E, Jansen S, Van Looveren D, Boeckx B, Geudens V, De Man J, Jochmans D, Wauters J, Wauters E, Vanaudenaerde BM, Lambrechts D, Neyts J, Dallmeier K, Thibaut HJ, Jacquemyn M, Maes P, Daelemans D. Baggen J, et al. Among authors: vanaudenaerde bm. Nat Genet. 2021 Apr;53(4):435-444. doi: 10.1038/s41588-021-00805-2. Epub 2021 Mar 8. Nat Genet. 2021. PMID: 33686287
Genetic variation in caveolin-1 affects survival after lung transplantation.
Vandermeulen E, Ruttens D, Verleden SE, Vos R, Van Raemdonck DE, Kastelijn EA, Wauters E, Lambrechts D, Nawrot TS, Cox B, Verleden GM, Vanaudenaerde BM. Vandermeulen E, et al. Among authors: vanaudenaerde bm. Transplantation. 2014 Aug 15;98(3):354-9. doi: 10.1097/TP.0000000000000058. Transplantation. 2014. PMID: 24621537
Successful double-lung transplantation from a donor previously infected with SARS-CoV-2.
Ceulemans LJ, Van Slambrouck J, De Leyn P, Decaluwé H, Van Veer H, Depypere L, Ceuterick V, Verleden SE, Vanstapel A, Desmet S, Maes P, Van Ranst M, Lormans P, Meyfroidt G, Neyrinck AP, Vanaudenaerde BM, Van Wijngaerden E, Bos S, Godinas L, Carmeliet P, Verleden GM, Van Raemdonck DE, Vos R. Ceulemans LJ, et al. Among authors: vanaudenaerde bm. Lancet Respir Med. 2021 Mar;9(3):315-318. doi: 10.1016/S2213-2600(20)30524-5. Epub 2020 Dec 1. Lancet Respir Med. 2021. PMID: 33275902 Free PMC article. No abstract available.
Distinct Airway Involvement in Subtypes of End-Stage Fibrotic Pulmonary Sarcoidosis.
Verleden SE, Vanstapel A, De Sadeleer L, Dubbeldam A, Goos T, Gyselinck I, Geudens V, Kaes J, Van Raemdonck DE, Ceulemans LJ, Yserbyt J, Vos R, Vanaudenaerde B, Weynand B, Verschakelen J, Wuyts WA. Verleden SE, et al. Chest. 2021 Aug;160(2):562-571. doi: 10.1016/j.chest.2021.01.003. Epub 2021 Jan 10. Chest. 2021. PMID: 33440183
Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis.
De Sadeleer LJ, McDonough JE, Schupp JC, Yan X, Vanstapel A, Van Herck A, Everaerts S, Geudens V, Sacreas A, Goos T, Aelbrecht C, Nawrot TS, Martens DS, Schols D, Claes S, Verschakelen JA, Verbeken EK, Ackermann M, Decottignies A, Mahieu M, Hackett TL, Hogg JC, Vanaudenaerde BM, Verleden SE, Kaminski N, Wuyts WA. De Sadeleer LJ, et al. Among authors: vanaudenaerde bm. Am J Respir Crit Care Med. 2022 Jan 1;205(1):60-74. doi: 10.1164/rccm.202103-0569OC. Am J Respir Crit Care Med. 2022. PMID: 34724391 Free PMC article.
The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
Goos T, Verleden SE, De Sadeleer LJ, Van Herck A, Sacreas A, Vanstapel A, Kaes J, Geudens V, Aelbrecht C, Ruttens D, Lambrechts D, Vermeer S, Ceulemans LJ, Van Raemdonck DE, Godinas L, Yserbyt J, Vanaudenaerde BM, Verleden GM, Vos R, Wuyts WA. Goos T, et al. Among authors: vanaudenaerde bm. Transpl Int. 2022 May 16;35:10159. doi: 10.3389/ti.2022.10159. eCollection 2022. Transpl Int. 2022. PMID: 35651878 Free PMC article.
252 results